IL-31 Rabbit Polyclonal Antibody
To Order: garrett@bioworldantibodies.com
 Polyclonal IL-31 Antibody |
|
APR06392G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-31 . This antibody is tested and proven to work in the following applications: |
 IL-31 Polyclonal Antibody |
|
ES8589-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against IL-31 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
IL-31 Polyclonal Antibody |
|
ES8589-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against IL-31 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
 XMIR-31 RNA oligo miRNA-31-5p with Xmotif |
|
XMIR-31 |
SBI |
10 rxn |
EUR 525.6 |
|
|
 AXMIR-31 RNA oligo anti-miRNA-31-5p with Xmotif |
|
AXMIR-31 |
SBI |
10 reactions |
EUR 525.6 |
|
|
 IL-31 Antibody |
|
3745-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
|
3745-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
|
3747-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
|
3747-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development. |
IL-31 Antibody |
|
24390-100ul |
SAB |
100ul |
EUR 468 |
IL-31 Antibody |
|
24391-100ul |
SAB |
100ul |
EUR 468 |
 Rabbit IL-31 ELISA Kit |
|
ERTI0041 |
Abclonal |
96Tests |
EUR 625.2 |
 IL-31 |
|
E21-053 |
EnoGene |
10ug |
EUR 411.6 |
 Anti-IL-31 Antibody |
|
A08339-1 |
BosterBio |
100ug/vial |
EUR 400.8 |
 Anti-IL-31 antibody |
|
STJ98951 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to IL-31. |
 XMIRXpress lentivector miRNA-31-5p with Xmotif |
|
XMIRXP-31 |
SBI |
10 ug |
EUR 812.4 |
|
|
 IL-31, Interleukin-31, human |
|
RC212-42 |
Bio Basic |
2ug |
EUR 125.26 |
|
|
 IL-31 Peptide |
|
3745P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (NT) IL-31 peptide |
IL-31 Peptide |
|
3747P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) IL-31 peptide |
 Recombinant Human Interleukin-31/IL-31 |
|
C053-10ug |
Novoprotein |
10ug |
EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
|
C053-1mg |
Novoprotein |
1mg |
EUR 3774 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
|
C053-500ug |
Novoprotein |
500ug |
EUR 2660.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Human Interleukin-31/IL-31 |
|
C053-50ug |
Novoprotein |
50ug |
EUR 595.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
 IL-20, Interleukin-20, human |
|
RC212-31 |
Bio Basic |
2ug |
EUR 125.26 |
|
|
 Anti-IL-31 alpha antibody |
|
STJ96456 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to IL-31Ralpha. |
IL-31 Rabbit Polyclonal Antibody
